“Managing Bevacizumab-Related Gastrointestinal Perforation In Hepatocellular Carcinoma (HCC) Patients: A Systematic Review”. 2025. The Review of Diabetic Studies, February, 1039-48. https://doi.org/10.70082/x94dvz94.